NKTX
Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.92
+4.66%Aug 11, 2026, 05:57 UTC
Nkarta reported a wider net loss of $40.37 million for Q2 2026, compared to $22.98 million in the prior-year quarter, due to higher operating expenses and lower other income.
Source: